Showing 641 - 660 results of 1,171 for search 'antibody effect function', query time: 0.14s Refine Results
  1. 641

    Real-World Evaluation of Dupilumab in the Long-Term Management of Eosinophilic Chronic Rhinosinusitis with Nasal Polyps: A Focus on IL-4 and IL-13 Receptor Blockade by Nicola Lombardo, Aurelio D’Ecclesia, Emanuela Chiarella, Corrado Pelaia, Debbie Riccelli, Annamaria Ruzza, Nadia Lobello, Giovanna Lucia Piazzetta

    Published 2024-12-01
    “…<i>Conclusions</i>: These results indicate that dupilumab may be an effective treatment for CRSwNP, offering significant symptom relief, improved olfactory function, and enhanced quality of life. …”
    Get full text
    Article
  2. 642

    A novel NFKB1 agonist remodels tumor microenvironment and activates dendritic cells to promote anti-tumor immunity in colorectal cancer by Ying Chen, Qiaoming Li, Zixiang Wang, Ling V. Sun, Steven X. Hou

    Published 2025-05-01
    “…Additionally, we showed that the combination of F1929-1458 and the anti-PD-1 antibody exhibited a synergistic anti-tumor effect. …”
    Get full text
    Article
  3. 643

    AN IMMUNOTHERAPEUTIC CONCEPT OF MICROBIAL ANTIGEN APPLICATION IN ATOPY AND DISORDERS ASSOCIATED WITH FACULTATIVE MICROFLORA, AS EXEMPLIFIED BY A POLYCOMPONENT IMMUNOVAC VP4 VACCINE by N. B. Egorova, E. A. Kurbatova

    Published 2014-07-01
    “…The therapeutic effect is accompanied by sufficient positive dynamics of immunological parameters, e.g., phagocytic activity of macrophages, increase in lymphocytes bearing CD4, CD8, CD16, CD72, CD21 markers, enhanced IFNγ and IFNα production, correction of Ig synthesis, increased antibody titers and affinity. …”
    Get full text
    Article
  4. 644

    PD-1 inhibition disrupts collagen homeostasis and aggravates cardiac dysfunction through endothelial-fibroblast crosstalk and EndMT by Zejin Zhang, Zejin Zhang, Zhenzhen Yan, Zhenzhen Yan, Tao Yuan, Tao Yuan, Xiaona Zhao, Xiaona Zhao, Minghui Wang, Minghui Wang, Guoqing Liu, Guoqing Liu, Lijun Gan, Wei Qin, Wei Qin, Wei Qin

    Published 2025-03-01
    “…Collagen plays a crucial role in maintaining cardiac structure, elasticity, and signal transduction; however, the effects and mechanisms of PD-1 inhibitor on cardiac collagen remodeling remain poorly understood.MethodsC57BL/6 mice were injected with anti-mouse PD-1 antibody to create a PD-1 inhibitor-treated model. …”
    Get full text
    Article
  5. 645

    DEVELOPMENT OF OPTIMAL EXPERIMENTAL THERAPEUTIC REGIMENS ADMINISTRATION OF IMMOBILIZED INTERFERON α-2b by O. G. Shitikova, E. Yu. Sherstoboev, N. V. Masnaya, M. G. Danilets, E. S. Trofimova, A. A. Ligacheva, P. G. Madonov, D. N. Kinsht, K. I. Ershov, M. A. Shilova

    Published 2014-10-01
    “…Experimental evaluation of immunotropic properties of immobilized interferon α-2b was carried out at in vivoexperiments in outbred CD1 male mice with using of following tests: the study of drug effect on the phagocytic activity of peritoneal leukocytes (the relative number of phagocytes and the number of bacteria which were assimilated by phagocytes were assessed); the study of drug effect on the humoral immune response (the total number of splenocytes, the relative and absolute number of antibody-forming cells and their functional activity were determined); estimation of drug effect on the cellular immune response with the using of delayed-type hypersensitivity test induced by sheep red blood cells. …”
    Get full text
    Article
  6. 646

    Severe Digoxin Toxicity in a Child Managed with Cholestyramine. A Case Report by Suman Noorani, Nadeem ullah Khan, Shahan Waheed, Hadia Iftikhar

    Published 2024-03-01
    “…Digoxin toxicity is a common problem in clinical practice because its therapeutic window is relatively narrow (from 0.5 to 2 ng/ml). The toxic effects occur at concentrations &gt; 2.8 ng/ml and are mainly related to disturbances of cardiac function and of circulatory system as well as GI and CNS disturbances. …”
    Get full text
    Article
  7. 647

    Impact of dietary-nucleotides and Saccharomyces cerevisiae-derivatives on growth-performance, antioxidant-capacity, immune-response, small-intestine histomorphometry, caecal-Clostr... by Tamer Mohamed Abo-Sriea, Elshaimaa Ismael, Basant Mohsen Sobhi, Neven H. Hassan, Ebtihal M. M. Elleithy, Sherif AbdElmonam Omar, Ahmed M Soliman, Khaled Nasr El-Din Fahmy, Amer Ramadan

    Published 2024-12-01
    “…Nucleotides and yeast cell-wall products are essential nutrients for broiler performance, gut function, and immune response. Antibiotics, like florfenicol, negatively affect the immune system. …”
    Get full text
    Article
  8. 648

    Rituximab induced lung injury by Rohit Chari, Youmna Abdelghany, Madeleine Purcell, Blaine Kenaa

    Published 2025-07-01
    “…Conclusion Rituximab and Cyclophosphamide are well described causes of acute pneumonitis post R-CHOP administration. Given curative effect of R-CHOP, careful changes in management plan and co-treatment with steroids could help preserve lung function while allowing for full continuation of the chemotherapy regimen.…”
    Get full text
    Article
  9. 649

    Preventing Candida albicans from subverting host plasminogen for invasive infection treatment by Si-Min Chen, Zui Zou, Shi-Yu Guo, Wei-Tong Hou, Xi-Ran Qiu, Yu Zhang, Li-Jun Song, Xin-Yu Hu, Yuan-Ying Jiang, Hui Shen, Mao-Mao An

    Published 2020-01-01
    “…Base on this finding, we discovered a mouse monoclonal antibody (mAb) 12D9 targeting C. albicans Eno1, with high affinity to the 254FYKDGKYDL262 motif in α-helices 6, β-sheet 6 (H6S6) loop and direct blocking activity for C. albicans capture host plasminogen. mAb 12D9 could prevent C. albicans from invading human epithelial and endothelial cells, and displayed antifungal activity and synergistic effect with anidulafungin or fluconazole in proof-of-concept in vivo studies, suggesting that blocking the function of cell surface Eno1 was effective for controlling invasive infection caused by Candida spp. …”
    Get full text
    Article
  10. 650
  11. 651
  12. 652

    Immunogenicity, Pathogenesis, and Host’s Immuno-Responses to Marburg Virus Infection by Emmanuel Edwar Siddig, Nicaise Ndembi, Ayman Ahmed, Claude Mambo Muvunyi

    Published 2025-03-01
    “…These gaps in knowledge are limiting our understanding of the disease and the implementation of cost-effective prevention and control measures including case management through safe and effective therapeutic modalities. …”
    Get full text
    Article
  13. 653

    IN VITRO CELLULAR INTERACTIONS DURING IMMUNE RESPONSE TO T CELLINDEPENDENT TYPE 2 ANTIGENS by M. V. Gavrilova, I. N. Chernyshova, D. A. Khochenkov, E. V. Sidorova

    Published 2014-07-01
    “…It was shown that DCs augmented viability of B1 and B2 lymphocytes. Functional activity of the B1 and B2 lymphocytes was determined by ELISPOT method, as relative numbers of antibody- and immunoglobulin-forming cells (AFCs and IFCs, respectively) detectable after four days in culture. …”
    Get full text
    Article
  14. 654

    Sex hormones and allergies: exploring the gender differences in immune responses by Jesús Alberto Gutiérrez-Brito, José Álvaro Lomelí-Nieto, José Francisco Muñoz-Valle, Edith Oregon-Romero, Jazz Alan Corona-Angeles, Jorge Hernández-Bello

    Published 2025-01-01
    “…Sex hormones control the reproductive system and have several immuno-modulatory effects affecting immune cells, including T and B cell development, antibody production, lymphoid organ size, and lymphocyte death. …”
    Get full text
    Article
  15. 655

    Duplication of the Rabies Virus Glycoprotein Enhances the Virus Propagation Rate and Immunogenicity by Ashkan Alamdary, Alireza Gholami, Mohammad Azizi, Zahra Noormohammadi

    Published 2025-07-01
    “…Glycoprotein (G) is a structural protein of the rabies virus that plays a crucial function in host protection against the virus. This study assessed the effects of integrating an extra copy of the glycoprotein gene into the rabies virus genome using reverse genetics on the immunogenicity and titer of the recombinant virus. …”
    Get full text
    Article
  16. 656

    An atlas of immune cell exhaustion in HIV-infected individuals revealed by single-cell transcriptomics by Shaobo Wang, Qiong Zhang, Hui Hui, Kriti Agrawal, Maile Ann Young Karris, Tariq M. Rana

    Published 2020-01-01
    “…An inhibitory receptor KLRG1 was identified in a HIV-1 specific exhausted CD8+ T cell population expressing KLRG1, TIGIT, and T-betdimEomeshi markers. Ex-vivo antibody blockade of KLRG1 restored the function of HIV-specific exhausted CD8+ T cells demonstrating the contribution of KLRG1+ population to T cell exhaustion and providing an immunotherapy target to treat HIV chronic infection. …”
    Get full text
    Article
  17. 657

    Booster vaccination against the SARS-CoV-2: mechanisms and efficiency by S. A. Berns, A. V. Veremeyev, A. A. Savicheva, A. Yu. Gorshkov, O. M. Drapkina

    Published 2023-12-01
    “…In addition, the immune system function in response to COVID-19 is considered, while the role of memory cells, antibody and cellular immunity reactions are emphasized.…”
    Get full text
    Article
  18. 658

    Modeling systems-level regulation of host immune responses. by Juilee Thakar, Mylisa Pilione, Girish Kirimanjeswara, Eric T Harvill, Réka Albert

    Published 2007-06-01
    “…We compare and discuss the effect of the species-specific virulence factors on disrupting the immune response during their infection of naive, antibody-treated, diseased, or convalescent hosts. …”
    Get full text
    Article
  19. 659

    Intrinsic PD‐L1 Degradation Induced by a Novel Self‐Assembling Hexapeptide for Enhanced Cancer Immunotherapy by Hongxia Zhang, Ming Ji, Yamei Wang, Mengmeng Jiang, Zongyu Lv, Gongyu Li, Lulu Wang, Zhen Zheng

    Published 2025-01-01
    “…This work addresses these challenges by developing a hexapeptide, KFM (Lys‐Phe‐Met‐Phe‐Met‐Lys), capable of both directly downregulating PD‐L1 and self‐assembling into a ROS‐responsive supramolecular hydrogel. This dual functionality allows Gel KFM to function as a localized drug delivery system and a PD‐L1 inhibitor. …”
    Get full text
    Article
  20. 660

    Use of rituximab in connective tissue disease-associated interstitial lung disease: a narrative review by Chenhao Xu, Zewei Xu, Jin Ren

    Published 2025-05-01
    “…The article synthesizes findings from studies assessing rituximab’s effects on lung function, clinical outcomes, and safety across distinct subtypes of connective tissue disease. …”
    Get full text
    Article